BiotechTube

romiplostim

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Thrombocytopenia

Conditions

Thrombocytopenia, Idiopathic Thrombocytopenic Purpura

Trial Timeline

Aug 11, 2009 → Jan 14, 2014

NCT ID
NCT00907478

About romiplostim

romiplostim is a approved stage product being developed by Amgen for Thrombocytopenia. The current trial status is completed. This product is registered under clinical trial identifier NCT00907478. Target conditions include Thrombocytopenia, Idiopathic Thrombocytopenic Purpura.

What happened to similar drugs?

1 of 20 similar drugs in Thrombocytopenia were approved

Approved (1) Terminated (2) Active (17)
✅Standard heparin (UFH) versus certoparin (LMWH)NovartisApproved
🔄avatrombopag (lower baseline platelet count) + placebo (lower baseline platelet count) + avatrombopag (higher baseline platelet count) + placebo (higher baseline platelet count)EisaiPhase 3
🔄avatrombopag (lower baseline platelet count) + placebo (lower baseline platelet count) + avatrombopag (higher baseline platelet count) + placebo (higher baseline platelet count)EisaiPhase 3
🔄Avatrombopag + Placebo + Standard of careEisaiPhase 3
🔄Romiplostim + PlaceboKyowa KirinPhase 3
🔄Hetrombopag Olamine + Hetrombopag Olamine ；Hetrombopag Olamine PlaceboJiangsu Hengrui MedicinePhase 3
🔄Hetrombopag + Hetrombopag plus Placebo + PlaceboJiangsu Hengrui MedicinePhase 3

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (15)

NCT IDPhaseStatus
NCT04673266Phase 2Active
NCT04478227Phase 1Completed
NCT04478123Phase 2Completed
NCT03362177Phase 3Completed
NCT03343847Phase 3Withdrawn
NCT02279173Phase 3Completed
NCT02052882Phase 2Completed
NCT01516619Phase 2Completed
NCT01143038Phase 2Completed
NCT01071954Phase 3Completed
NCT00907478ApprovedCompleted
NCT00303472Phase 2Completed
NCT00508820Phase 3Completed
NCT00116688Phase 3Completed
NCT00117143Phase 1/2Completed

Competing Products

20 competing products in Thrombocytopenia

See all competitors
ProductCompanyStageHype Score
Pirtobrutinib + PlaceboEli LillyPhase 1/2
39
Anti-(integrin beta-3) human monoclonal antibodyRallybioPhase 2
17
Placebo + LusutrombopagShionogiPhase 2
27
LusutrombopagShionogiPhase 2
27
Avatrombopag + Avatrombopag + PlaceboEisaiPhase 2
35
avatrombopagEisaiPhase 1
29
E5501 + Drug: E5501EisaiPhase 1
29
avatrombopag (lower baseline platelet count) + placebo (lower baseline platelet count) + avatrombopag (higher baseline platelet count) + placebo (higher baseline platelet count)EisaiPhase 3
40
avatrombopag + PlaceboEisaiPhase 2
35
Avatrombopag + Placebo + Pegylated interferon (PEG-IFN) + Telaprevir + RibavirinEisaiPhase 2
35
avatrombopag (lower baseline platelet count) + placebo (lower baseline platelet count) + avatrombopag (higher baseline platelet count) + placebo (higher baseline platelet count)EisaiPhase 3
40
Avatrombopag + Placebo + Standard of careEisaiPhase 3
40
RomiplostimKyowa KirinPhase 1/2
32
Romiplostim + PlaceboKyowa KirinPhase 3
40
Romiplostim (AMG-531)Kyowa KirinPhase 2
35
Romiplostim and danazolKyowa KirinPhase 2
31
ONO-7746Ono PharmaceuticalPhase 1
21
Hetrombopag OlamineJiangsu Hengrui MedicinePhase 1
29
Hetrombopag Olamine + Hetrombopag Olamine ；Hetrombopag Olamine PlaceboJiangsu Hengrui MedicinePhase 3
47
Hetrombopag OlamineJiangsu Hengrui MedicinePhase 2
42